文献速递间质性肺疾病肺栓塞与肺血管病呼吸道感染

内皮间质转化:COVID-19后间质性肺纤维化与血管闭塞的前驱?

Endothelial to mesenchymal transition: a precursor to post-COVID-19 interstitial pulmonary fibrosis and vascular obliteration?
PubMed 文献 · Eur Respir J · 2020-10-15

本文为针对Huertas等社论的读者来信,基于尸检肺组织比较研究,强调SARS-CoV-2感染中内皮细胞功能障碍,提出内皮间质转化(EndMT)可能是COVID-19后肺纤维化与血管重塑的重要机制,值得进一步研究。

要点

  • SARS-CoV-2可经ACE2、TMPRSS2、弗林蛋白酶、唾液酸及CD147等介导进入宿主细胞。
  • COVID-19尸检肺组织显示ACE2阳性内皮细胞显著增多,伴内皮形态改变、细胞连接破坏、细胞肿胀及基底膜分解。
  • 上述内皮结构改变与EndMT过程一致,可能参与感染后肺纤维化与血管闭塞。

核心结论

  • EndMT可能是COVID-19后间质性肺纤维化与血管闭塞的重要前驱机制。

研究设计与样本

  • 本文为读者来信,引用并讨论一项比较COVID-19、H1N1所致ARDS及年龄匹配未感染对照尸检肺组织的研究。

主要发现

  • COVID-19死亡者尸检肺组织中ACE2阳性内皮细胞显著增加,并见内皮细胞形态明显改变、细胞间连接破坏、细胞肿胀及基底膜分解。
  • 上述改变提示血管结构重塑,与内皮间质转化(EndMT)过程一致。

临床怎么用

  • 在COVID-19随访中应关注内皮功能障碍及EndMT相关机制,警惕肺纤维化与血管闭塞的发生。

局限性

  • 本文为读者来信,未报告原始研究数据、样本量或统计值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Endothelial to mesenchymal transition (EndMT) could lead to post-COVID-19 pulmonary fibrosis and vascular remodelling https://bit.ly/2QqSKxT We read with interest the recent editorial by Huertas et al. [1], highlighting the importance of endothelial cell dysfunction in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The authors have made some very fascinating insights, and we would like to take this discussion further, especially emphasising the role of endothelial cells in initiating post-infection pulmonary fibrosis and vascular remodelling. The angiotensin-converting enzyme 2 (ACE2) has been suggested as the primary receptor for mediating SARS-CoV-2 entry into the host cells. Apart from ACE2, the other key players that facilitate SARS-CoV-2 entry, includes transmembrane serine protease 2 (TMPRSS2), furin, sialic acid and the extracellular matrix metalloproteinase inducer (CD147) [1]. In their article, the authors provide compelling comprehensions from a study comparing post mortem lung tissues from patients who died from coronavirus disease 2019 (COVID-19), acute respiratory distress syndrome due to influenza A (H1N1) infection and those from age-matched, uninfected control lungs [1, 2]. A crucial inference was the connections between the significant increase in ACE2 positive endothelial cells and the substantial change in endothelial cell morphology, disruption of intercellular junctions, cell swelling, and the breakdown of the underlying basement membrane, all indicative of vascular structural modification in tune to the process of endothelial to mesenchymal transition (EndMT) [3]. Considering the implications for post-COVID-19 pulmonary fibrosis and vascular destruction seen in this infectious pathology, we believe that the role of EndMT in disease manifestation could be consequential.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Eapen MS, Lu W, Gaikwad AV, et al. Endothelial to mesenchymal transition: a precursor to post-COVID-19 interstitial pulmonary fibrosis and vascular obliteration? Eur Respir J. 2020. PMID: 32859681. doi:10.1183/13993003.03167-2020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。